OraSure Technologies OSUR Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net revenues by Product | |||||
| COVID-19 | $13.76M-1.9% | $14.02M— | —— | $243.32M+217% | |
| HIV | $49.8M-34.3% | $75.84M+24.7% | $60.82M+56.7% | $38.81M-7.9% | |
| Non-product and services revenues | $5.97M+391% | $1.22M-62.6% | $3.25M-65.5% | $9.43M+39.2% | |
| Risk Assessment Testing | $1.87M-84.1% | $11.73M+20.5% | $9.74M-5.2% | $10.27M+6.1% | |
| Sample Management Solutions | $38.36M-29.8% | $54.65M+0.7% | $54.27M-14.3% | $63.34M-12.8% | |
| Net revenues by Geography | |||||
| Africa | $25.06M-23.5% | $32.75M+11.9% | $29.25M+61.2% | $18.15M— | |
| Europe | $7.38M-12.4% | $8.42M+3.9% | $8.11M-29.7% | $11.54M-16.4% | |
| Other regions | $4.55M-18.9% | $5.6M— | —— | —— | |
| United States | $78.03M-43.9% | $139.06M-61.6% | $361.66M+3.3% | $350.21M+85.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does OraSure Technologies break its business down?
- OraSure Technologies (OSUR) reports net revenues by product across 7 parts — COVID-19, HCV, HIV, Non-product and services revenues and Other Product And Services Revenues. Each is extracted from the segment footnotes and tracked over time.
- Where does OraSure Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in OraSure Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
